Market Cap

Medigen Vaccine Biologics Corp Market Capitalization:

TW$23.16 Billion

TWD as of Jan. 1, 2024

US$754.7 Million

business Medigen Vaccine Biologics Corp Company Profile

Medigen Vaccine Biologics Corp Main Stock Listing

TWSE: 6547

Market Capitalization History of Medigen Vaccine Biologics Corp

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Medigen Vaccine Biologics Corp market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$23.16 B -0.59%
Jan. 1, 2023 TW$23.30 B -71.91%
Jan. 1, 2022 TW$82.94 B 146.12%
Jan. 1, 2021 TW$33.70 B 221.37%
Jan. 1, 2020 TW$10.49 B -7.52%
Jan. 1, 2019 TW$11.34 B -0.14%
Jan. 1, 2018 TW$11.36 B 19.20%
Jan. 1, 2017 TW$9.53 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Medigen Vaccine Biologics Corp Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

Medigen Vaccine Biologics Corp has the following listings and related stock indices.


Stock: TWSE: 6547

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.